DYNAVAX TECHNOLOGIES DVAX (NASDAQ)

$ 1.47
19:09
Change: -0.04 (-2.65%)
Volume: 106,300

Avg. Volume: 105835
P/E Ratio: 0
EPS (Annual): -1.19
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 39,810
Institutional Shareholders: 62.31%
Last: 1.47
Change: -0.04 (-2.65%)
Prev. Close: 1.51
Open: 1.55
Day's Range: 1.46 - 1.59
52wk Range: 1.32 - 6.55
Market Value: 60,110
Beta: 2.01
12-month EPS Change: 0.00%
Total Return Last 12 Months: -69.38%
Total Return Last 3 Years: -108.96%
Total Return Last 5 Years: -84.36%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 0.00%


Headlines on DVAX
Alert me Subscribe

Dynavax shares plummet on allergy drug failure

(BERKELEY, Calif.)Shares of Dynavax Technologies Corp. plummeted Friday after the drug developer said it is ending development of its ragweed allergy drug Tolamba after it failed a midstage trial.READ MORE
May 16, 2008 9:52AM
Keywords: DVAX, MRK

Premarket Movers: GE rises, Dynavax falls

(NEW YORK)Shares of General Electric Co. rose in premarket trading Friday after the company confirmed it plans to sell or spin-off its century-old appliance business.READ MORE
May 16, 2008 9:17AM
Keywords: GE, AAP, DVAX, HOKU

Ahead of the Bell: Dynavax

(NEW YORK)Wall Street is waiting to find out if a pause in testing a Hepatitis B vaccine by Dynavax technologies Corp. and Merck & Co. is a brief delay or a sign of greater trouble.READ MORE
Mar 18, 2008 8:24AM
Keywords: MRK, DVAX

FDA Halts Merck, Dynavax Vaccine Studies

(WHITEHOUSE STATION, N.J.)Merck Inc. and Dynavax said Monday federal regulators have halted studies of their experimental hepatitis vaccine due to safety concerns. The Food and Drug Administration placed a ...READ MORE
Mar 17, 2008 5:10PM
Keywords: MRK, DVAX

Out of the Gate: Dynavax Up on Upgrade

(NEW YORK)Dynavax Technologies Corp. shares climbed Friday after an Oppenheimer analyst upgraded the stock, predicting approval and eventual success for Dynavax's hepatitis B vaccine candida...READ MORE
Feb 22, 2008 10:33AM
Keywords: DVAX, MRK, GSK
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN +28.80 60.41
AMYLIN PHARMA I -56.90 21.11
GILEAD SCIENCES +15.20 47.85
BIOGEN IDEC INC -20.40 48.59
GENENTECH INC +33.90 96.64